Response to correspondence on an exploratory prospective phase II study of preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed glioblastoma
Article in Journal of Neuro-Oncology (August 2024)
The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.
Status of alternative angiogenic pathways in glioblastoma resected under and after bevacizumab treatment
Article in Brain Tumor Pathology (April 2024)
Forkhead box transcription factors (FOXOs and FOXM1) in glioma: from molecular mechanisms to therapeutics
Article in Cancer Cell International (October 2023)